Horm Metab Res 2011; 43(3): e1
DOI: 10.1055/s-0030-1268483
Erratum
© Georg Thieme Verlag KG Stuttgart · New YorkCombination Therapy with Nateglinide and Telmisartan Ameliorates Insulin Resistance
in Zucker Fatty Rats by Suppressing Advanced Glycation End Product Receptor Axis
K. Miura1
, Y. Kitahara1
, T. Kajioka1
, M. Takeuchi2
, S. Yamagishi3
- 1Exploratory Research Laboratories, Ajinomoto Pharmaceuticals Co. Ltd., Kawasaki, Japan
- 2Department of Life Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University,
Kanazawa, Japan
- 3Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications,
Kurume University School of Medicine, Kurume, Japan